Sunday, 25 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
Deals
Prudential Hong Kong Collaborates with Foshan Fosun Chancheng Hospital for Direct Payment Services
May 9, 2025
Company
Deals
Sanyou Medical Partners with CGBio to Launch Regenerative Medicine Joint Venture
May 9, 2025
Company
Drug
Hengrui Pharma Files for New Dalpiciclib Indication in Early Breast Cancer
May 9, 2025
Company
Deals
Gilead Sciences Announces $11 Billion Investment in US Expansion
May 9, 2025
Company
Drug
Humanwell Healthcare Gains NMPA Approval for Giapreza Generic in Shock Therapy
August 26, 2025
Company
Drug
Humanwell Healthcare Gains NMPA Clearance for HZ-J001 Cream in Vitiligo Trial
August 26, 2025
Company
Deals
Pfizer Partners with HSITP to Boost Life Sciences Innovation in Greater Bay Area
May 9, 2025
Company
Deals
Insilico Medicine Files for IPO to Leverage AI in Drug Discovery
May 9, 2025
Company
Drug
Pfizer’s Zavicefta Approved by China’s NMPA for Severe Infections in All Ages
May 9, 2025
Company
Drug
Amgen’s Tepezza Approved in UK for Thyroid Eye Disease Treatment
May 9, 2025
Company
Deals
Guangzhou Regenverse Therapeutics Raises RMB 100 Million in Pre-Series A Financing
May 8, 2025
Company
Novo Nordisk Reports 18% YOY Revenue Growth in Q1 2025
May 8, 2025
1
2
…
22
23
24
25
26
27
28
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?